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Abstract—Our group pioneered the study of nerve regen-
eration in China and has successfully developed human
‘‘acellular nerve grafts (ACNGs)’’. However, our clinical
studies revealed that the effects of ACNGs for long and large
nerve defects are far from satisfactory. To improve the
efﬁcacy of ACNGs, we combined Cartilage oligomeric
matrix protein angiopoietin-1 (COMP-Ang1) with ACNGs
in rat sciatic nerve injury models and observed the outcomes
via angiographic, morphological, and functional analyses.
Co-cultures of endothelial cells (ECs) and dorsal root
ganglion neurons (DRGs) were also used to characterize
the relationship between neovascularization and nerve re-
generation. The results showed signiﬁcant improvements in
early neovascularization, nerve regeneration, and functional
outcomes in vivo in the ACNG + COMP-Ang1 group. In
vitro, neurite length, and density as well as the expression
levels of neuroﬁlament 68 (NF68) and phosphorylated-Tie-2
(p-Tie-2) signiﬁcantly increased when ECs were co-cultured
with DRGs using COMP-Ang1. p-Tie-2 expression dra-
matically decreased after treatment with a Tie-2 kinase
inhibitor (S157701), which consequently decreased the level
of NF68. COMP-Ang1 can be concluded to promote early
neovascularization followed by brisk nerve regeneration, and
the mechanism of this regeneration may involve the modula-
tion of the p-Tie-2 and Tie-2 receptors on ECs. These
ﬁndings demonstrate that ACNGs can be modiﬁed using
COMP-Ang1 to improve their efﬁcacy in repairing peripheral
nerve defects in clinical trials.
Keywords—Acellular nerve graft, Extracellular matrix, Nerve
regeneration, Tissue engineering, Neovascularization.
INTRODUCTION
Autologous nerve grafts, the current ‘‘gold stan-
dard’’ for the treatment of peripheral nerve defects,
suﬀer from their inherent disadvantages, and a suitable
alternative has long been sought after. At present,
acellular tissue matrix is an attractive material for tis-
sue repair in biologically derived materials. Our group
pioneered the study of nerve regeneration in China and
has successfully produced human ‘‘acellular nerve
grafts (ACNGs)’’.22 However, our clinical studies re-
vealed that the clinical prognoses of nerve defects are
far from satisfactory, especially for long and large
nerve defects. A meta-analysis of our previous studies
showed that graft length is an independent predictor of
prognosis, and longer defects indicate poorer recov-
ery.23 Improving the efﬁcacy of ACNGs for short and
long nerve defects is a major issue in current research.
Previous studies demonstrated that the rate of axonal
regeneration was increased near blood vessels, sug-
gesting an interaction between regenerating axons and
blood vessels.44 Thus, numerous studies focused on
revealing the interaction between neovascularization
and nerve regeneration using growth factors,25,39,40
angiopoietins,30,31 and Schwann cell (SC)/endothelial
cell (EC) co-cultures.17 The vascular and neural sys-
tems are architecturally similar yet execute distinct
functions. They share common molecular pathways
that regulate cell fate during development.5 For
example, the branching patterns of peripheral sensory
nerves and small skin arteries are related. SCs release
vascular endothelial growth factor (VEGF), which in-
structs blood vessels to branch along the nerves.38
Therefore, the relationship between vascular biology
and neuroscience helps us to discover new mechanistic
insights and therapeutic opportunities.5
VEGF and angiopoietin-1 (Ang1) are both potent
pro-angiogenic factors that can eﬃciently prompt
vessel formation. Hobson et al.25 found that VEGF
can enhance intraneural angiogenesis and improve
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nerve regeneration after axotomy, while Ang1, based
on its angiogenic properties, has been proposed as a
therapeutic strategy to target microvascular diseases in
several experimental models.30,31,41 However, the use
of Ang1 is limited due to its short working duration.
Recently, cartilage oligomeric matrix protein an-
giopoeitin-1 (COMP-Ang1) has been developed as a
soluble, stable, and potent Ang1 variant.28,32 COMP-
Ang1 was generated by replacing the N-terminal por-
tion of Ang1 with the short coiled-coil domain of
cartilage oligomeric matrix protein.7,26 This new pro-
tein more potently phosphorylates the Tie-2 receptor
than native Ang1, which allows the receptor to
function more effectively. Long-term and sustained
exposure to COMP-Ang1 was shown to facilitate long-
lasting vascular enlargement and blood ﬂow enhance-
ment.9 Additionally, COMP-Ang1 is more actively
involved in EC migration, pericyte recruitment, and
blood vessel formation, remodeling and maturation
than the native protein.6,21 Akt and p38 MAPK
phosphorylation have been shown to be important
mediators downstream of Ang1 and are involved in
angiogenesis and axon growth.8,19 This study aimed to
investigate the interactions between nerve regeneration
and neovascularization after the administration of
COMP-Ang1 to rats with a sciatic nerve injury.
Moreover, ECs and dorsal root ganglion neurons
(DRGs) were co-cultured to investigate the mechanism
by which COMP-Ang1 prompts neovascularization
and nerve regeneration.
MATERIALS AND METHODS
Sciatic Nerve Defect Repaired by ACNG Combined
with COMP-Ang1 (In Vivo)
Our study was approved by the Ethics Committee of
the Medical College of the First Aﬃliated Hospital of
Sun Yat-sen University. The review number is [2013]
A-055. This study included 151 healthy female adult
Sprague–Dawley (SD) rats (average weight 200–250 g)
from the Experimental Animal Center of the First
Aﬃliated Hospital of Sun Yat-sen University. The rats
were given a standard diet and cared for with standard
procedures.
Preparation of ACNGs
Fifty healthy rats were selected as donors for the
nerve allografts. These rats were anesthetized with an
intraperitoneal injection of 10% chloral hydrate
(0.3 mL/100 g body weight) (Sinopharm Chemical
Reagent Co., Ltd., Shanghai, China). The bilateral
sciatic nerves (‡20 mm in length) were excised from the
rats, cleaned of external fat and connective tissue and
immediately placed in sterile phosphate-buﬀered saline
(PBS). The nerve segments were treated with chemical
detergents to remove cellular components as previ-
ously described.22,46 Brieﬂy, the nerve segments were
agitated in deionized distilled water for 7 h and treated
with 3% (v/v) Triton X-100 (Sigma-Aldrich, St. Louis,
MO, USA) overnight, followed by treatment with 4%
(w/v) sodium deoxycholate (Sigma-Aldrich, St. Louis,
MO, USA) for an additional 24 h. After thorough
washing in 10 mM PBS, the extracted acellular nerves
were subjected to cobalt-60 irradiation (25 kGy g ra-
diation) for 12 h (Guangzhou Huada Biological
Technology Co., Ltd., Guangzhou, China) and stored
in 10 mM PBS at 4 C until use.
Surgical Procedure
A total of 90 rats (200–250 g) survived the ex-
periment and were randomly divided into two groups:
a control group (ACNG group) and a test group
(ACNG + COMP-Ang1 group). Each group consist-
ed of 45 animals. All surgical procedures were per-
formed by the same surgeon under aseptic operating
conditions using 10% chloral hydrate anesthesia
(0.3 mL/100 g body weight). The incision was made on
the lateral side of the left thigh to expose the sciatic
nerve. With the aid of a surgical microscope, a 10-mm
segment of the nerve was removed and microsurgically
repaired using a 12-mm ACNG. Penicillin G (10,000
U) (Sigma, Deisenhofen, Germany) was postop-
eratively injected into the quadriceps femoris for
3 days. In the ACNG + COMP-Ang1 group, all rats
received daily intraperitoneal injections of COMP-
Ang1 (5 lL/g body weight, Enzo Life Sciences,
Farmingdale, NY, USA), while rats in the ACNG
group received daily doses of a 0.9% NaCl solution
(5 lL/g body weight, i.p.). All rats were housed in
cages in a warm environment and permitted free access
to food and water.
Evaluation of Neovascularization
Lead oxide (Pb3O4, Chengdu Jinshan Chemical
Reagent Co., Ltd., Chengdu, Sichuan, China) (50%,
w/v) was mixed with a 5% (w/v) gelatin solution and
kept in a 40 C water bath. Five rats in each group
were randomly selected at speciﬁc time intervals: 7, 14,
and 21 days after surgery. The rats were anesthetized
with an intraperitoneal injection of 10% chloral hy-
drate (0.3 mL/100 g body weight). The carotid artery
was exposed, and the perfusion agents (10 mL/200 g
body weight) were injected into the artery after arterial
catheterization. Perfusion was stopped after discol-
oration of the sclera and extremities was noted. A
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one-step injection of the perfusion agent was ensured
throughout the perfusion process. After successful
systemic perfusion, the bilateral sciatic nerves of the
rats were carefully exposed and dissected.48 Subse-
quently, 15 mm of nerve tissue was harvested from the
inferior margin of the piriformis and ﬁxed in 4%
paraformaldehyde for 30 min, then treated with 30%
sucrose for 3 h. The harvested nerves were scanned by
microCT (ZKKS-MCT-III, Guangzhou Zhongke
Kaisheng Medical Technology Co., Ltd., Guangzhou,
Guangdong, China) (voltage, 40 kV peak; power,
45 W; four frames every 0.72 of rotation; total rota-
tion range, 360; total scanning duration, 28 min). The
acquired image information was input into Mimics
10.0 software to observe the state of visualization for
each aspect of the specimen and establish a visual
observation model.
The microvessel volume (mm3) and total volume of
peripheral nerves (mm3) weremeasured, and the vascular
index (VI) and volume fracture (VF)were calculated. The
VI was calculated using the following formula: total area
of vascular development region/cross-sectional area of
nerves 9 100%. Volume fracture refers to the vascular
content per unit area in the peripheral nerves to be tested
and was calculated using the following formula: total
microvascular volume of the inspected nerves/total vol-
ume of the inspected nerves 9 100%.Data are expressed
as the mean ± standard deviation. SPSS 13.0 (SPSS,
Inc., Chicago, IL, USA) was used to perform the inde-
pendent t test. Statistical signiﬁcance was set at p< 0.05.
Molecular Biology Evaluation During Nerve
Regeneration
On days 14, 21, and 28, rats in each group were
randomly selected and sacriﬁced to harvest the nerve
grafts (n = 5). All nerves were ﬁxed in 4%
paraformaldehyde for 24 h at 4 C, followed by de-
hydration in a 20% sucrose solution for 24 h and a
second dehydration in 30% sucrose solution for an-
other 24 h.
The nerve samples were serially sectioned at a
thickness of 5 lm on a freezing microtome (Leica
CM3050S; Leica, Wetzlar, Germany) and collected on
superfrost/plus slides (Cytotest; Jiangsu Cytotest
Experimental Supplies Co., Ltd., Haimen, Jiangsu,
China). For each sample, ten sections per animal were
randomly selected from the medium part. Im-
munoﬂuorescence studies were performed using a
monoclonal anti-neuroﬁlament 200 (NF200) (Sigma-
Aldrich, N4142, USA, 1:200). The staining procedure
was performed as described in previous studies.43,46
Images of the stained sections were captured with a
ﬂuorescence microscope attached to a CCD spot
camera (DFC350FX/DMIRB; Leica). Neuroﬁlament
expression was measured based on the integral optical
density (IOD) of the NF200-immunoreactive area us-
ing Image Pro Plus 6.0 (IPP) software (Media Cyber-
netics, MA). The images of graft segment were
converted to gray scale 8 using IPP, and the color
range was selected. Finally, the computerized optical
density representing neuroﬁlament expression was
calculated using the measure and count function. Data
are expressed as the mean ± standard deviation. SPSS
13.0 was used to perform the independent t test. Sta-
tistical signiﬁcance was set at p< 0.05.
Eight weeks after the operation, rats were selected
from each group and anesthetized for neuronal tracing
(n = 5). The left sciatic nerve was carefully exposed
and separated from the fascia and muscle. Ten mi-
croliters of 2% ﬂuoro-gold was injected into the rat
sciatic nerve trunk at a point distal to the grafts; the
axons were then allowed to absorb the solution. After
14 days, the rats were sacriﬁced to harvest their dorsal
root ganglions and spinal cord.13 For each sample, 5
sections (16 lm thickness) of ganglion and spinal cord
(20 lm thickness) were randomly selected and
mounted on glass slides. Neurons labeled with FG
were counted in each ganglion or spinal cord section
under a ﬂuorescence microscope. Ten high-power
ﬁelds per specimen were randomly selected and ana-
lyzed with IPP. SPSS 13.0 was used to perform the
independent t test. Statistical signiﬁcance was set at
p< 0.05.
The gastrocnemius muscles were simultaneously
harvested for hematoxylin and eosin (HE) staining,
and the graft segments were harvested for transmission
electron microscopy (n = 5).47 The muscle samples
were post-ﬁxed with formalin, embedded in parafﬁn,
and sectioned transversely (4 lm thickness). For each
sample, ﬁve sections of gastrocnemius (4 lm thickness)
were randomly selected. The sections were deparaf-
ﬁnized, rehydrated in an ethanol series, and stained
with HE. The ultrathin sections were stained with lead
citrate and uranyl acetate and then examined under a
Philips CM120 transmission electron microscope
equipped with an image acquisition system at 98000
magniﬁcation to measure the thickness of the myelin
sheaths. Photographs from ten random ﬁelds of each
ultrathin nerve section were analyzed using IPP.
At 12 weeks, toluidine blue (Chengdu Jinshan
Chemical Reagent Co., Ltd., Chengdu, Sichuan, Chi-
na) staining was performed as previously described.47
Brieﬂy, nerve graft segments were harvested and
quickly immersed in 2.5% Na–cacodylate-buffered
glutaraldehyde solution for 2 h, ﬁxed for 2 h in 2%
Na–cacodylate-buffered osmium tetroxide, serially
dehydrated in increasing concentrations of ethanol,
inﬁltrated with and embedded in Epon 812 (Ted Pella,
Redding, CA, USA), sectioned (4 lm thickness), and
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ﬁnally stained with toluidine blue to evaluate the efﬁ-
cacy of nerve regeneration. Transection was performed
at the middle of the nerve graft segments. The average
number of myelinated axons and the ﬁber diameter
were analyzed using an Olympus BX60 microscope
and IPP software. For each sample, photographs of
three random ﬁelds were taken and analyzed to mea-
sure the number of axons and their diameters. SPSS
13.0 was used to perform the independent t test. Sta-
tistical signiﬁcance was set at p< 0.05.
Functional Evaluation of the Sciatic Nerve
The sciatic functional index (SFI) was tested 2, 4, 6,
8, 10, and 12 weeks after the surgery.11 The rats of
each group (n = 5) were placed in a conﬁned walkway
with a dark shelter at the end, and the investigators
were blinded to the animal treatment groups during the
walking track analysis. The electrophysiological eval-
uation was performed 12 weeks after the surgery. The
injured nerves were exposed after anesthetization.
Electrical stimuli were applied to the nerve trunks at
the distal or proximal portions of the grafting site, and
the compound muscle action potentials (CMAPs) and
nerve conduction velocity (NCV) were recorded on the
triceps surae muscle belly using a portable biological
function experimental system (BL-420F; Tai Meng,
Inc., Chengdu, China). Data are expressed as the
mean ± standard deviation. SPSS 13.0 was used to
perform the independent t test. Statistical signiﬁcance
was set at p< 0.05.
Observation of the Interaction Between Angiogenesis
and Nerve Regeneration (In Vitro)
A human umbilical vein endothelium-derived cell
line, ECV304, was obtained from a lab at the Cell
Culture Experimental Animal Center of Sun Yat-sen
University. Dorsal root ganglions were harvested from
3-day-old postnatal SD rats according to established
procedures.31
The ganglions were obtained from 6 SD neonates
and cultured in ﬂasks with Dulbecco’s modiﬁed Eagle
medium (DMEM)/F-12 medium (Gibco, USA) con-
taining 10% fetal bovine serum (FBS, Gibco, USA),
1% penicillin–streptomycin solution (Gibco, USA),
2 mM forskolin (Sigma-Aldrich, Tokyo, Japan), and
100 ng/mL nerve growth factor (NGF, Sigma-Aldrich,
USA). The ﬂasks were kept in a humidiﬁed atmosphere
of 5% CO2 in air at 37 C for 24 h. After being cul-
tured with the medium containing 10% fetal bovine
serum and NGF, all cells grew slowly. The neu-
rotrophic effects of NGF increased the viability of
neurons to accelerate their growth, while the low serum
concentration inhibited the activities of other cells in
dorsal root ganglions, including ﬁbroblasts and SCs.
The DRGs were divided into ﬁve groups, group A
(DRGs), group B (DRGs treated with 100 ng/mL
COMP-Ang1), group C (ECV304/DRGs co-culture),
group D (ECV304/DRGs co-culture treated with
100 ng/mL COMP-Ang1), and group E (ECV304/
DRGs co-culture treated with 100 ng/mL COMP-
Ang1 + 250 nM Tie-2 kinase inhibitor S157701 (Sel-
lect, Houston, USA)). The cells were trypsinized and
plated in a 24-well plate at a density of 2 9 105 cells
per well for the former two groups and 1 9 105 cells
per well for the latter three groups. The cells were
cultured for 24 h before co-culture. The ECV 304 cells
were thawed and plated in a Transwell (0.4 lm pore
size, Millipore, USA) at a density of 1 9 105 cells per
well. The Transwell layer was placed on top of the
conﬂuent layer of DRGs for the co-culture groups. In
group E, 250 nM S157701 was added to the well, and
the cells were cultured for 1 h. The groups were then
subjected to different conditions (listed above in the
bracket after the different groups) for 72 h.
All specimens were ﬁxed with 2% paraformaldehy-
de (dissolved in 0.01 M PBS) for 30 min and then de-
hydrated in 5% sucrose at 37 C for 15 min. This step
was followed by incubation with 10% normal goat
serum for 1 h. Subsequently, monoclonal mouse anti-
NF200 antibody (Sigma-Aldrich, USA, 1:200) and
monoclonal rabbit anti-b-tubulin antibody (Sigma-
Aldrich, USA, 1:300) were added to the specimens,
which were then incubated with the cells at 4 C
overnight. Goat anti-mouse antibody (Cell Signaling
Technology, USA, 1:400) and goat anti-rabbit anti-
body (Cell Signaling Technology, USA, 1:500) were
then added, and the samples were incubated for 1 h.
Lastly, the samples were incubated with 2 lg/mL
DAPI (Merck, Germany) for 10 min.
The neurite length and number of perikarya per 0.5-
mm area were assessed as established in previous
studies.31 To assess neurite length, a 400-lm diameter
circle was drawn around a single neuron, and the total
length of NF200-positive neurites (including ﬁrst and
higher orders) lying within the circle was measured.
Thirty neurons were studied per group, and each ex-
periment was repeated three times. To calculate the
number of perikarya, ﬁve high-power ﬁelds were ran-
domly selected in one culture well. The NF200-positive
neurons in a 0.5-mm2 area were then counted. The cells
were lysed in RIPA buffer (19 PBS, 1% NP40, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate,
and the protease inhibitor cocktail Roche) with
phenylmethanesulfonyl ﬂuoride on ice for 30 min and
then centrifuged for 10 min at 15,0009g and 4 C to
extract protein. The protein samples were separated
by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (10% Bis–Tris gel), transferred to
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FIGURE 1. 3D-vessel reconstruction of grafts at 7 (a1, b1), 14 (a2, b2) and 21 days (a3, b3) after surgery. The 3D vascular study
indicated that vessels had already recanalized in the ACNG + COMP-Ang1 group but not in the ACNG group at 14 days. Scale
bars 5 100 lm.
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polyvinylidene ﬂuoride membranes (Millipore, Bed-
ford, USA), and blocked with 5% bull serum albumin
for 1 h, followed by incubation with mouse anti-neu-
roﬁlament 68 (NF68) (Cell Signaling Technology,
USA, 1:1000), b-actin (Sigma-Aldrich, USA, 1:1500),
rabbit anti-Tie-2 (Cell Signaling Technology, USA,
1:1000), or rabbit anti-phosphorylation-Tie-2 (Cell
Signaling Technology, #4226, USA, 1:1000) antibody
at 4 C overnight. After washing, the membrane was
incubated with peroxidase-conjugated secondary anti-
body for 1 h at room temperature, washed in Tris-
buffered saline containing tween and developed using
an enhanced chemiluminescence system (Millipore,
USA). SPSS 13.0 was used to perform one-way
ANOVA. Statistical signiﬁcance was set at p< 0.05.
RESULTS
Relationship Between Neovascularization and Nerve
Regeneration (In Vivo)
Qualitative and Quantitative Evaluation
of Neovascularization
Figure 1 shows the three-dimensional (3D) vessel
reconstruction of grafts 7, 14, and 21 days after sur-
gery. After 14 days, the vessels had already recanalized
in the ACNG + COMP-Ang1 group but not in the
ACNG group. Both the VF and VI were higher in the
ACNG + COMP-Ang1 group than in the ACNG
group on days 7 and 14. COMP-Ang-1 yielded VF
values of 5.56 ± 1.67% vs. 2.24 ± 0.42 (p< 0.05) on
FIGURE 2. Relationship between neovascularization and nerve regeneration in terms of the blood vessel VF, blood vessel VI and
neurofilament IOD. Both VF (day 7 and day 14) and VI (day 7) were higher in the ACNG + COMP-Ang1 group than in the ACNG
group. The IOD was greater in the ACNG + COMP-Ang1 group than in the ACNG group throughout the experiment (a and b).
**p< 0.01 and *p< 0.05. Mean 6 SD.
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days 7, 6.78 ± 1.22% vs. 5.05 ± 1.31% (p< 0.05) on
days 14, while VF did not signiﬁcantly differ between
these two groups after 21 days (8.02 ± 1.11% vs.
7.13 ± 0.46%, p> 0.05). COMP-Ang-1 yielded VI
values of 22.31 ± 1.89% vs. 15.27 ± 0.80% (p< 0.05)
on days 7, while VI did not signiﬁcantly differ between
these two groups after 14 days (23.30 ± 3.31 vs.
21.68 ± 1.52, p> 0.05) and 21 days (21.35 ± 3.24 vs.
22.43 ± 3.61, p> 0.05) (Figs. 2a and 2b).
Morphological Evaluation of Nerve Regeneration
Obvious changes in the NF200 protein levels could
be observed in both groups on days 14, 21, and 28
(Fig. 3). However, the IOD was higher in the
ACNG + COMP-Ang1 group than in the
ACNG group, with values of 114,000 ± 21,596
vs. 15,166 ± 10,107 (p< 0.05), 243,833 ± 26,407 vs.
139,833 ± 62,703 (p< 0.05), and 418,333 ± 74,944 vs.
330,166 ± 51,615 (p< 0.05) on days 14, 21, and 28,
respectively (Figs. 2a and 2b). Eight weeks after sur-
gery, FG retrograde labeling revealed that more axons
crossed the grafts in the ACNG + COMP-Ang1
group than in the ACNG group. Dorsal root ganglions
(Figs. 4a1 and 4b1) and motor neurons (Figs. 4a2 and
4b2) in the ACNG + COMP-Ang1 group ﬂuoresced
more strongly than those in the ACNG group,
with values of 73.33 ± 7.39 vs. 55.33 ± 12.72 (p<
0.05) and 3.00 ± 0.89 vs. 1.50 ± 0.43 (p< 0.05),
FIGURE 3. NF200 immunoreactivity of the ACNG group and the ACNG + COMP-Ang1 group at 14 days (a1, b1), 21 days (a2, b2)
and 28 days (a3, b3) after surgery. Almost no NF200 expression was found in the ACNG group at 14 days, and the NF200-positive
cells in the ACNG + COMP-Ang1 group were distributed sporadically 14 days after surgery. At 21 and 28 days, neurofilaments
could be identified in both groups, and the NF200-positive cells increased more quickly in the ACNG + COMP-Ang1 group than in
the ACNG group. Scale bars 5 50 lm.
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respectively, indicating that COMP-Ang1 increased
number of axons labeled with retrograde transport dye
(Figs. 4c1 and 4c2). H&E staining of the gastrocne-
mius muscles in the ACNG + COMP-Ang1 group
demonstrated thicker and more compact myoﬁbers
(Figs. 5a1 and 5a2). In addition, the nerve ultrastruc-
ture observed via transmission electronic microscopy
demonstrated that the nerves in the ACNG + COMP-
Ang1 group had more myelinated axons and thickened
sheaths, and they appeared more organized than to
those of the ACNG group (Figs. 5b1 and 5b2).
After 12 weeks, toluidine blue staining (transverse
sections) showed that the nerve grafts in the
ACNG + COMP-Ang1 group were more compact,
uniform, and organized in structure than those in the
ACNG group. The axons signiﬁcantly diﬀered between
the two groups, with a higher average diameter
(2.34 ± 0.30 vs. 1.76 ± 0.15 lm, p< 0.05) and more
myelinated axons (4860 ± 870 vs. 3780 ± 540/mm2,
p< 0.05) in the ACNG + COMP-Ang1 group
than in the ACNG group. The nerve grafts in the
ACNG + COMP-Ang1 group were more compact,
uniform and organized in structure than those in the
ACNG group (Fig. 6).
Functional Evaluation of Nerve Regeneration
The SFI was calculated every 2 weeks (2, 4, 6, 8, 10,
and 12 weeks) after surgery. Compared to the ACNG
group, signiﬁcant improvement could be observed at
FIGURE 4. FG retrograde tracing to examine the reverse transportation capability of neurons. The density of FG-labeled sensory
neurons is indicated by an arrow in the dorsal root ganglions (a1, b1), and the motor neurons are indicated by an arrow in the
spinal cord (a2, b2). DRGs (Figs. 4a1 and 4b1) and motor neurons (Figs. 4a2 and 4b2) fluoresced more strongly in the ACNG + -
COMP-Ang1 group than in the ACNA group, indicating that COMP-Ang1 can increase retrograde transport in the regenerating
nerves. Magnified photographs of a2 (a3) and b2 (b3). Scale bars 5 50 lm.
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10 weeks (51.33 ± 4.41 vs. 69.33 ± 6.78, p< 0.05) and
12 weeks (43.67 ± 5.20 vs. 50.17 ± 6.40, p< 0.05) in
the group that received COMP-Ang1. The CMAPs
increased in the ACNG + COMP-Ang1 group
(0.74 ± 0.10 vs. 0.45 ± 0.10, p< 0.05) accompanied
by a higher NCV (0.74 ± 0.96 vs. 0.52 ± 0.83,
p< 0.05) (Fig. 7). COMP-Ang1 could be concluded to
improve nerve function after nerve repair.
Interaction Between Angiogenesis and Nerve
Regeneration (In Vitro)
Morphological and Quantitative Evaluation of DRG
Co-cultures
The bar chart for group A shows that DRGs had
sparse NF200-positive neurite outgrowth, fewer peri-
karya, and slightly reduced NF68 protein levels;
groups A and B did not signiﬁcantly diﬀer (Figs. 8 and
9). When DRGs were co-cultured with ECV 304, the
neurons showed promising neurite elongation and in-
creased NF68 expression compared with group A,
287.00 ± 61.58 vs. 164.8 ± 50.13 lm (p< 0.05) and
0.77 ± 0.16 vs. 0.54 ± 0.23 (p< 0.05), respectively
(Figs. 9a and 9b). Though more perikarya could be
observed in group C (Fig. 8), groups A and C did not
signiﬁcantly differ. The addition of COMP-Ang1 to
the co-culture system increased the perikarya and
NF68 protein level in group D compared with group
C, 19.00 ± 6.06 vs. 11.83 ± 4.92 (p< 0.05) and
1.06 ± 0.15 vs. 0.77 ± 0.15 (p< 0.05), respectively.
However, neurite length did not signiﬁcantly differ
between groups C and D (Fig. 8). In group E, in which
a Tie-2 kinase inhibitor was used to inhibit Tie-2
function, neurite length, perikarya counts and NF68
expression dramatically decreased compared with
group D, 259.67 ± 25.04 vs. 372.00 ± 92.16 lm
(p< 0.05), 12.67 ± 3.61 vs. 19.00 ± 6.06 (p< 0.05),
and 1.06 ± 0.15 vs. 0.73 ± 0.08 (p< 0.05), respec-
tively (Fig. 8). These results imply that p-Tie-2 likely
plays a key role in the COMP-Ang1-mediated accel-
eration of neurite growth in the ECV304/DRGs co-
culture system.
Mechanism Analysis of COMP-Ang1
The western blot data of the Tie-2/p-Tie-2 level
indicate that the expression of Tie-2 did not
signiﬁcantly diﬀer between groups C and D
(0.99 ± 0.14 vs. 0.97 ± 0.13, p> 0.05) (Figs. 9a and
FIGURE 5. H&E staining of gastrocnemius muscle and ultrastructure of sciatic nerves. Arrows show thicker and more compact
myofibers of the gastrocnemius in the COMP-Ang1 group (a2) compared with the control group (a1). Electron microscopy showed
well-organized axons and thicker myelination in the COMP-Ang1 group (b1, b2). Scale bars 5 50 lm.
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9c), but the level of p-Tie-2 was higher in group D than
in group C (0.63 ± 0.09 vs. 0.90 ± 0.14, p< 0.05)
(Figs. 9a and 9d). When the phosphorylation of Tie-2
was blocked with a Tie-2 kinase inhibitor in group E,
the level of p-Tie-2 dramatically decreased compared
with group D (0.90 ± 0.14 vs. 0.53 ± 0.16, p< 0.05),
which subsequently decreased the expression of NF68
(1.04 ± 0.15 vs. 0.73 ± 0.08, p< 0.05).
DISCUSSION
The close association of peripheral nerves and blood
vessels is an anatomical and functional relationship
that has been known for centuries but has not been
well described in a molecular and developmental con-
text. Termed ‘‘neurovascular congruence,’’ this asso-
ciation stipulates that a growing nerve follows speciﬁc
guidance cues produced by the vasculature to ulti-
mately reach its appropriate targets.20 Consequently,
blood supply is very important for peripheral nerve
grafts.
Previous studies demonstrated that moderate neo-
vascularization directly accelerates SC proliferation,35
improves vessel wall permeability,3 and subsequently
promotes nerve regeneration,24,33 provided that the
invasion of obstructive granular tissue is controlled to
a low level.2,4 Conversely, a variety of neurotrophic
factors were continuously transported to provide nu-
trition to SCs, while the membrane established an ideal
substrate for nerve regeneration.15 The most exhaus-
tively studied angiopoietins are Ang1 and Ang2. Ang1
is a critical player in vessel maturation, and it mediates
the migration, adhesion and survival of ECs. Ang2
disrupts the connections between the endothelium and
perivascular cells and promotes cell death and vascular
regression. However, Ang2 also promotes neovascu-
larization in conjunction with VEGF. Thus, VEGF,
Ang1, and Ang2 may play complementary and coor-
dinated roles in airway angiogenesis and microvascular
remodeling, and therapeutic intervention may reverse
these structural changes.27 Many studies focused on
the therapeutic implications of targeting these angio-
genic factors. Concerning the effect of VEGF on
FIGURE 6. Toluidine blue staining (transverse sections) of the harvested grafts from the ACNG group (a1) and the ACNG + -
COMP-Ang1 group (a2) 12 weeks after nerve grafting. Compared with the ACNG group, the neural architecture was more organized
in the ACNG + COMP-Ang1 group in terms of the average diameter of the nerve (b1) or the number of myelinated axons (b2).
*p< 0.05. Error bars correspond to the mean 6 S.D. Scale bars 5 50 lm.
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vascular formation, VEGF administration reportedly
results in leaky, immature, and unstable vessels.34 In
comparison, Ang1 is an angiogenic factor that plays
important roles in the stabilization and maturation of
blood vessels during angiogenesis.42 Ang1 also coun-
teracts VEGF-induced inﬂammation in ECs while
having an additive effect on vessel formation.10 Ang1 is
a critical angiogenic factor for vascular maturation
and enhances VEGF-induced angiogenesis in a com-
plementary manner.16
Null mutation studies showed that Ang1 and its re-
ceptor Tie-2, a transmembrane tyrosine kinase uniquely
expressed by ECs, are essential to developmental angio-
genesis and are anti-apoptotic and neurotrophic to the
neurons of the central and peripheral nervous system
in vitro.30,31 The bifunctional trophic action of Ang1 on
bothbloodvessels andnerveﬁbers suggest thatAng1may
have a wider therapeutic range, including beneﬁcial ef-
fects in the treatment of nerve injury. COMP-Ang1more
potently phosphorylates the Tie-2 receptor than native
Ang1.7,28,32 Thus, it may be more effectively involved in
EC migration, pericyte recruitment and the formation,
remodeling andmaturationof bloodvessels.41Moreover,
it can facilitate neurogenesis, thereby coordinating the
healing injured nerve ﬁbers and endoneural microves-
sels.5,35,45 Studies show that Akt and p38 MAPK phos-
phorylation are important downstream mediators of
COMP-Ang1 and are involved in angiogenesis and axon
growth.14,32 COMP-Ang1 induces the phosphorylation
of Akt (Ser 473) and p38 MAPK (Thr180/Tyr182),32
suggesting that the angio- and neurotrophic actions of
COMP-Ang1 in sciatic nerves involve the phosphoryla-
tion of Akt and p38 MAPK upon the Tie-2 receptor.
The in vivo experiments showed that VF (day 7 and
day 14), VI (day 7) and NF200 IOD (day 14, 21, and
28) were higher in the ACNG + COMP-Ang1 group
than in the ACNG group. After 14 days, some NF200-
positive ﬁbers were sporadically distributed in the
ACNG + COMP-Ang1 group, while their expression
was low in the ACNG group. Even though the number
of NF200-positive ﬁbers increased in both groups
thereafter, the ﬂuorescence remained stronger in the
FIGURE 7. Electrophysiological evaluation of nerve regeneration. Significantly increased CMAPs (a), NCV (b), and SFI (c) in the
ACNG + COMP-Ang1 group indicated that COMP-Ang1 improved the functional recovery of the transected sciatic nerve. *p< 0.05,
**p< 0.01. Error bars correspond to the mean 6 SD.
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FIGURE 8. Morphologies of DRGs under various culture conditions (group A: DRGs alone, group B: DRGs with 100 ng/mL COMP-Ang1,
group C: ECV304/DRGs co-culture, group D: ECV304/DRGs co-culture with 100 ng/mL COMP-Ang1, group E: ECV304/DRGs co-culture
with 100 ng/mL COMP-Ang1 + 250 nM Tie-2 kinase inhibitor S157701). As an index of neurite outgrowth, the length of NF-positive neurites
of first and higher orders was measured within a 400-lm diameter circle around the perikaryon (see circle in group A). Significantly longer
neurite length in ECV304/DRGs co-culture and ECV304/DRGs co-culture with COMP-Ang1. Number of NF-positive perikarya determined in
0.5-mm2 area per culture well. Significantly higher perikarya number in the ECV304/DRGs co-culture with COMP-Ang1 than in the ECV304/
DRGs co-culture. The Tie-2 kinase inhibitor S157701 dramatically decreased the neurite length and number of perikarya in the ECV304/
DRGs co-culture with COMP-Ang1. *p<0.05 and **p<0.01. Error bars correspond to the mean 6 SD. Scale bars 5 200 lm.
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ACNG + COMP-Ang1 group than in the ACNG
group. Taken together, the FG retrograde labeling,
gastrocnemius atrophy, ultrastructure analysis, sciatic
function and toluidine blue staining analysis (Figs. 4,
5, 6, and 7) clearly demonstrate the relationship be-
tween neovascularization and nerve regeneration. The
results reveal that COMP-Ang1 increased the level of
FG in the spinal cord, which suggested that the reverse
transport of DRGs and motor neurons was improved.
Moreover, decreased gastrocnemius atrophy, better
sciatic function recovery and a well-organized neural
architecture were also evident in the ACNG +
COMP-Ang1 group after surgery, which indicate that
COMP-Ang1 effectively promotes angiogenesis and
axon regeneration. Here, we hypothesize that the fol-
lowing two pathways facilitate the beneﬁcial effects of
COMP-Ang1 on ACNG:
(1) The promotion of neovascularization into
the ACNG, which directly accelerates SC
FIGURE 9. Western blot analysis of NF68, Tie-2 and phosphorylated-Tie-2 in various conditions (group A: DRGs alone, group B:
DRGs with 100 ng/mL COMP-Ang1, group C: ECV304/DRGs co-culture, group D: ECV304/DRGs co-culture with 100 ng/mL COMP-
Ang1, group E: ECV304/DRGs co-culture with 100 ng/mL COMP-Ang1 + 250 nM Tie-2 kinase inhibitor S157701). NF-immunore-
active bands (gray value analysis) confirmed that COMP-Ang1 administration significantly increased NF68 in ECV304/DRGs co-
culture after the application of COMP-Ang1 (a, b). Tie-2 did not differ among these groups, but the level of p-Tie-2 was higher than
that in the ECV304/DRGs co-culture (a, d). However, p-Tie-2 dramatically decreased when the phosphorylation of Tie-2 was blocked
(a, d), which further decreased NF68 expression (a, b). *p< 0.05 and **p< 0.01. Error bars correspond to the mean 6 S.D. Scale
bars 5 200 lm.
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proliferation. The in vivo experiment veriﬁed
that COMP-Ang1 may accelerate vessel for-
mation to improve the nerve regeneration of
the ACNG. At 14 days, the 3D vascular study
clearly showed that vessels had already re-
canalized in the ACNG + COMP-Ang1
group but not in the ACNG group. Moreover,
the blood supply was larger and more abun-
dant in the ACNG + COMP-Ang1 group
throughout the experiment. An anatomical
study showed that the density of capillaries in
the ganglion capsules of dorsal root ganglions
and peripheral nerves was high. These capil-
laries are highly permeable to various com-
pounds, which may be indispensable to
maintain the normal function of nerve tissue.1
Furthermore, they may provide directional
information for nerves to reach their target
organs.12,18 Therefore, the early neovascular-
ization of acellular nerve allografts may
overcome a major current challenge in the
nerve bioengineering ﬁeld. Our investigation
showed that COMP-Ang1 can accelerate the
early neovascularization of nerve grafts, which
not only aids the early invasion of inﬂamma-
tory cells and removes fragments at the site
but also imports numerous factors to nourish
the injured nerve.35
(2) Direct anti-apoptotic and neurotrophic effects
on neurons. Although we did not carry out
this part in this paper, Kosacka et al.30,31
found that Ang1 directly affects the axonal
outgrowth of sensory neurons in vitro. When
the Tie-2 receptor was blocked with the anti-
Tie-2 antibody, neurite outgrowth was
severely impeded, which supported that
COMP-Ang1 may have anti-apoptotic and
neurotrophic effects on neurons.30 We show
that NF68 expression was increased in the
ECV304/DRGs co-culture compared with
DRG monoculture, and COMP-Ang1 sig-
niﬁcantly increased this effect in the co-culture
system. Despite the lack of obvious differences
in Tie-2 between the two co-culture systems
described above, COMP-Ang1 signiﬁcantly
increased the expression of p-Tie-2 in the
ECV304/DRGs co-culture system. Tie-2 ki-
nase inhibitor did not change the expression
of Tie-2 in the ECV/DRGs co-culture system
treated with COMP-Ang1. However, the
phosphorylation of Tie-2 was blocked, and
p-Tie-2 expression dramatically decreased,
which consequently decreased the expression
of NF68. These results indicate that the dif-
ference in NF68 levels correlated with the
difference in p-Tie-2 levels, which signiﬁed
FIGURE 10. COMP-Ang1 modulates the phosphorylation of Tie-2 in ECs, and ECs secrete trophic factors to affect the regen-
eration of neurons (a and b).
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that the activation of Tie-2 may play an un-
derlying role in the neurite outgrowth of
DRGs.
Although previous studies have demonstrated the
direct eﬀects of Ang1,29,30 its indirect inﬂuence was not
as obvious. We found that DRGs have longer neurites
and are more viable when co-cultured with ECs
(ECV304) than when cultured alone and that COMP-
Ang1 could signiﬁcantly enhance this effect. As shown
in previous studies, ECs and neural cells exhibit several
layers of cross-talk that affect neurogenesis and neural
cell fate.5 Gibran et al. have demonstrated that ECs
can produce NGF, which can prompt neurite out-
growth.19 In addition, ECs can release neurogenic
factors, such as brain-derived nerve factor (BDNF), to
promote nerve repair.35 Here, we hypothesize that ECs
may release various growth factors that signiﬁcantly
impact the nerve regeneration of the COMP-Ang1-
targeted Tie-2 pathway (Figs. 10a and 10b). Thus,
other neurotrophic factors secreted by ECs, such as
NGF and BDNF, may play an important role in
neurogenesis.37
In summary, this study included in vivo and in vitro
experiments to investigate the role of COMP-Ang1 in
improving ACNG efﬁcacy when repairing peripheral
nerve defects. It supported that COMP-Ang1 im-
proved the neovascularization of ACNG to promote
nerve regeneration in vivo. A series of experiments to
elucidate the mechanism of COMP-Ang1 showed that
COMP-Ang1 was angiogenic and could enhance neu-
rogenesis when neural cells (DRGs) were co-cultured
with ECs in vitro. However, several limitations of this
study should be noted: (1) we failed to establish a 3D
ECV304/DRGs co-culture system to detect the role of
COMP-Ang1/Tie-2 in angiogenesis; (2) we conﬁrmed
that COMP-Ang1 enhanced neovascularization but
could not detect speciﬁc neurotrophic factors due to
neovascularization in vivo and in vitro; (3) we initially
selected NF200 for the ﬂuorescence staining and
western blot analyses. However, the NF200 bands in
the western blot analysis were not as clear as desired
for practical applications. Therefore, we selected NF68
antibodies for the western blot analysis based on a
literature search.30,31,36 (4) The defect length was in-
sufﬁcient because the animals were small. Our anato-
mical studies indicated that the maximal length of the
sciatic nerve that needed to be cut in rats was ap-
proximately 17 mm. Because nerve tissue can retract
immediately after being cut due to its elasticity and all
ACNGs need to be trimmed after extraction, a 17-mm
nerve graft shortens to only 12 mm. Though a long
defect in a human is deﬁned as having a minimum
length of 30 mm, nerves in rats were often shorter than
17 mm in the lower extremities. Larger animals, such
as rhesus monkeys, which are more closely related to
humans than rats, could be used as feasible models to
verify the efﬁcacy of COMP-Ang1 in repairing long
and large nerve defects. We will further investigate the
interaction between neovascularization/angiogenesis
and axon regeneration and answer the above questions
in future studies.
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